Skip to main content

Advertisement

SpringerLink
Log in

Clinical Significance of Microvessel Count in Patients with Metastatic Liver Cancer Originating from Colorectal Carcinoma

  • Hepatobiliary and Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Microvessel count (MVC) has been correlated with patient prognosis in hepatocellular carcinoma. We investigated whether MVC assessed by staining with CD34 antibody was associated with disease-free and overall survival in patients with metastatic liver cancer (MLC).

Methods

We examined relationships between MVC and clinicopathologic factors or postoperative outcomes in 139 MLC patients who underwent hepatectomy between 1990 and 2006. CD34 expression was analyzed by the immunohistochemical method.

Results

MVC was associated with fibrous pseudocapsular formation on histological examination. By means of the modern Japanese classification of liver metastasis, poorer survival was associated with higher score, poorly differentiated adenocarcinoma, higher preoperative carcinoembryonic antigen (CEA) level, fibrous pseudocapsular formation, and smaller surgical margin. Shorter disease-free survival was associated with higher score when the Japanese classification of liver metastasis was used, multiple or bilobar tumor, regional lymph node metastasis in primary colon carcinoma, preoperative CEA level, fibrous pseudocapsular formation, and smaller surgical margin (<5 mm). Higher MVC (≥406/mm2) was associated with decreased disease-free and overall survival by univariate analysis (P = .034 and P = .021, respectively), and higher MVC represented an independently poor prognostic factor in overall survival by Cox multivariate analysis (risk ratio, 2.71; P = .023) in addition to histological differentiation.

Conclusions

Tumor MVC seems to be a useful prognostic marker of MLC patient survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jaeck D, Oussoultzoglou E. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol. 2007;14:3297–8.

    Article  PubMed  Google Scholar 

  2. Kato T, Yasui K, Hirai T, et al. herapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum. 2003;46(Suppl):S22–31.

    PubMed  Google Scholar 

  3. Sasaki A, Iwashita Y, Shibata K, et al. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg. 2005;9:374–80.

    Article  PubMed  Google Scholar 

  4. Kokudo N, Miki Y, Sugai S, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002;137:833–40.

    Article  PubMed  Google Scholar 

  5. Nanashima A, Yamaguchi H, Sawai T, et al. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection. J Gastroenterol Hepatol. 1999;14:1004–9.

    Article  PubMed  CAS  Google Scholar 

  6. Molleví DG, Serrano T, Ginestà MM, et al. utations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 2007;28:1241–6.

    Article  PubMed  CAS  Google Scholar 

  7. Saad RS, Kordunsky L, Liu YL, et al. Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol. 2006;19:1317–23.

    Article  PubMed  CAS  Google Scholar 

  8. Tanaka K, Shimada H, Fujii Y, et al. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg. 2004;389:371–9.

    Article  PubMed  Google Scholar 

  9. Onogawa S, Kitadai Y, Tanaka S, et al. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci. 2004;95:32–9.

    Article  PubMed  CAS  Google Scholar 

  10. Barozzi C, Ravaioli M, D’Errico A, et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer. 2002;94:647–57.

    Article  PubMed  CAS  Google Scholar 

  11. Ito K, Hibi K, Ando H, et al. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma. Jpn J Clin Oncol. 2002;32:54–8.

    Article  PubMed  Google Scholar 

  12. Thelen A, Scholz A, Benckert C, et al. VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. Int J Cancer. 2008;122:2471–81.

    Article  PubMed  CAS  Google Scholar 

  13. Ueda T, Oda T, Kinoshita T, et al. Neovascularization in pancreatic ductal adenocarcinoma: microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas. Oncol Rep. 2002;9:239–45.

    PubMed  Google Scholar 

  14. Pang RW, Joh JW, Johnson PJ, et al. Biology of hepatocellular carcinoma. Ann Surg Oncol. 2008;15:962–71.

    Article  PubMed  Google Scholar 

  15. Sun B, Zhang S, Zhang D, et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep. 2006;16:693–8.

    PubMed  CAS  Google Scholar 

  16. Nanashima A, Ito M, Sekine I, et al. Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers. Dig Dis Sci. 1998;43:2634–40.

    Article  PubMed  CAS  Google Scholar 

  17. Nanashima A, Yamaguchi H, Sawai T, et al. Prognostic factors in hepatic metastases of colorectal carcinoma: immunohistochemical analysis of tumor biological factors. Dig Dis Sci. 2001;46:1623–8.

    Article  PubMed  CAS  Google Scholar 

  18. Japanese Society for Cancer of the Colon and Rectum. 3.2.2.H. In: Mutoh T, editor. General rules for clinical and pathological studies on cancer of the colon, rectum and anus (in Japanese). 7th ed. Tokyo: Kanehara; 2006. p. 14–5.

  19. Takeda A, Stoeltzing O, Ahmad SA, et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol. 2002;9:610–6.

    Article  PubMed  Google Scholar 

  20. Nash AD, Baca M, Wright C, Scotney PD. The biology of vascular endothelial growth factor-B (VEGF-B). Pulm Pharmacol Ther. 2006;19:61–9.

    Article  PubMed  CAS  Google Scholar 

  21. Takeda A, Shimada H, Imaseki H, et al. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers. Oncol Rep. 2000;7:333–8.

    PubMed  CAS  Google Scholar 

  22. Nanashima A, Yoshinaga M, Yamaguchi H, et al. An immunohistochemical study of tumor vascularity and proliferation activity in cholangiocellular carcinoma: relationship to clinicopathologic factors and prognosis after hepatic resection. Acta Med Nagasaki. 2003;48:23–7.

    Google Scholar 

  23. Fortner JG, Silva JS, Golbey RB, et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 1984;199:306–16.

    Article  PubMed  CAS  Google Scholar 

  24. Iwatsuki S, Esquivel CO, Gordon RD, et al. Liver resection for metastatic colorectal cancer. Surgery. 1986;100:804–10.

    PubMed  CAS  Google Scholar 

  25. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254–62.

    Article  PubMed  CAS  Google Scholar 

  26. Jaeck D, Bachellier P, Guiguet M, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg. 1997;84:977–80.

    Article  PubMed  CAS  Google Scholar 

  27. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566–71.

    Article  PubMed  CAS  Google Scholar 

  28. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–18.

    Article  PubMed  CAS  Google Scholar 

  29. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487–99.

    Article  PubMed  CAS  Google Scholar 

  30. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–66.

    Article  PubMed  Google Scholar 

  31. Nagashima I, Takada T, Matsuda K, et al. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg. 2004;11:79–83.

    Article  PubMed  Google Scholar 

  32. Korita PV, Wakai T, Shirai Y, et al. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol. 2007;14:3472–80.

    Article  PubMed  Google Scholar 

  33. Okano K, Yamamoto J, Kosuge T, et al. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer. 2000;89:267–75.

    Article  PubMed  CAS  Google Scholar 

  34. Miyagawa S, Miwa S, Soeda J, et al. Morphometric analysis of liver macrophages in patients with colorectal liver metastasis. Clin Exp Metastasis. 2002;19:119–25.

    Article  PubMed  Google Scholar 

  35. Harada Y, Ogata Y, Shirouzu K. Expression of vascular endothelial growth factor and its receptor KDR/Flk-1 as prognostic factors in human colorectal cancer. Int J Clin Oncol. 2001;6:221–8.

    Article  PubMed  CAS  Google Scholar 

  36. Rajaganeshan R, Prasad R, Guillou PJ, et al. The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. Br J Cancer. 2007;96:1112–7.

    Article  PubMed  CAS  Google Scholar 

  37. Neal CP, Garcea G, Doucas H, et al. Molecular prognostic markers in resectable colorectal liver metastases: a systematic review. Eur J Cancer. 2006;42:1728–43.

    Article  PubMed  CAS  Google Scholar 

  38. Chan LS, Malcontenti-Wilson C, Muralidharan V, Christophi C. Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis. Anticancer Res. 2007;27:2317–23.

    PubMed  CAS  Google Scholar 

  39. Duff SE, Jeziorska M, Rosa DD, et al. Vascular endothelial growth factors and receptors in colorectal cancer: implications for anti-angiogenic therapy. Eur J Cancer. 2006;42:112–7.

    Article  PubMed  CAS  Google Scholar 

  40. Board RE, Valle JW. Metastatic colorectal cancer: current systemic treatment options. Drugs. 2007;67:1851–67.

    Article  PubMed  CAS  Google Scholar 

  41. Tappenden P, Jones R, Paisley S, Carroll C. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. Health Technol Assess. 2007;11:1–128.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Atsushi Nanashima MD, Kenichirou Shibata MD, Syuuichi Tobinaga MD, Masato Araki MD, Masaki Kunizaki MD, Hiroaki Takeshita MD, Shigekazu Hidaka MD, Terumitsu Sawai MD, Takeshi Nagayasu MD & Toru Yasutake MD

  2. Department of Molecular Pathology, Atomic Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Toshiyuki Nakayama MD

Authors
  1. Atsushi Nanashima MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenichirou Shibata MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiyuki Nakayama MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Syuuichi Tobinaga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masato Araki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaki Kunizaki MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroaki Takeshita MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shigekazu Hidaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Terumitsu Sawai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takeshi Nagayasu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Toru Yasutake MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toru Yasutake MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nanashima, A., Shibata, K., Nakayama, T. et al. Clinical Significance of Microvessel Count in Patients with Metastatic Liver Cancer Originating from Colorectal Carcinoma. Ann Surg Oncol 16, 2130–2137 (2009). https://doi.org/10.1245/s10434-009-0459-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0459-8

Keywords

Search

Navigation